Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017
ByNatasza Posielski, MD,Hannah Koenig, MPH,On Ho, PhD,Christopher R. Porter, MD,John Paul Flores, MD
Published: | Updated:
Patients 70 years or older that received neoadjuvant chemotherapy and radical cystectomy had better overall survival than those undergoing radical cystectomy alone.
